CA2775276C - Compositions and methods for the prevention and treatment of metabolic diseases - Google Patents

Compositions and methods for the prevention and treatment of metabolic diseases Download PDF

Info

Publication number
CA2775276C
CA2775276C CA2775276A CA2775276A CA2775276C CA 2775276 C CA2775276 C CA 2775276C CA 2775276 A CA2775276 A CA 2775276A CA 2775276 A CA2775276 A CA 2775276A CA 2775276 C CA2775276 C CA 2775276C
Authority
CA
Canada
Prior art keywords
bone
milk
proteins
hydroxyapatite
ntx
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2775276A
Other languages
English (en)
French (fr)
Other versions
CA2775276A1 (en
Inventor
Rajan V. Vembu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2775276A1 publication Critical patent/CA2775276A1/en
Application granted granted Critical
Publication of CA2775276C publication Critical patent/CA2775276C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CA2775276A 2009-09-24 2010-09-24 Compositions and methods for the prevention and treatment of metabolic diseases Active CA2775276C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24550509P 2009-09-24 2009-09-24
US61/245,505 2009-09-24
PCT/US2010/050202 WO2011038230A2 (en) 2009-09-24 2010-09-24 Compositions and methods for the prevention and treatment of metabolic diseases

Publications (2)

Publication Number Publication Date
CA2775276A1 CA2775276A1 (en) 2011-03-31
CA2775276C true CA2775276C (en) 2021-07-06

Family

ID=43796456

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2775276A Active CA2775276C (en) 2009-09-24 2010-09-24 Compositions and methods for the prevention and treatment of metabolic diseases

Country Status (8)

Country Link
US (4) US8518453B2 (cg-RX-API-DMAC7.html)
EP (1) EP2480099B1 (cg-RX-API-DMAC7.html)
JP (1) JP2013505950A (cg-RX-API-DMAC7.html)
AU (1) AU2010298141B2 (cg-RX-API-DMAC7.html)
CA (1) CA2775276C (cg-RX-API-DMAC7.html)
NZ (1) NZ599184A (cg-RX-API-DMAC7.html)
RU (1) RU2565020C2 (cg-RX-API-DMAC7.html)
WO (2) WO2011037957A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011037957A2 (en) 2009-09-24 2011-03-31 U.S. Foods & Pharmaceuticals, Inc. Compositions and methods for bone repair, maintenance and regeneration
CN103599521A (zh) * 2013-11-08 2014-02-26 苏州冉新生物技术有限公司 一种复合维生素d冲剂
BE1027357B1 (nl) * 2019-06-12 2021-01-18 Vanlommel Maria Kristel Voedingssupplement voor versnelde genezing

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615664A (en) * 1969-12-05 1971-10-26 Foremost Mckesson Treatment of whey
US3896241A (en) * 1971-09-01 1975-07-22 Coca Cola Co Preparation of a whey protein concentrate
US4572837A (en) * 1984-06-28 1986-02-25 The British Food Manufacturing Industries Research Association Protein product
NL9001692A (nl) * 1990-04-26 1991-11-18 Cooeperatieve Melkproductenbed Werkwijze voor de bereiding van een olie-in-water emulsie.
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
US7033610B2 (en) * 1990-07-13 2006-04-25 Gropep Pty, Ltd. Growth-promoting agent
JP3604159B2 (ja) * 1992-05-07 2004-12-22 雪印乳業株式会社 乳清由来の骨芽細胞増殖促進及び骨強化因子ならびに該因子を含有せしめた骨強化食品、医薬および飼料
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
US5639501A (en) * 1995-01-31 1997-06-17 Vembu; Rajan Separation of minerals from whey permeate
US5912032A (en) * 1995-05-11 1999-06-15 Meiji Milk Products Company, Limited Process of producing calcium-supplemented milk drinks
JP3454487B2 (ja) * 1995-06-29 2003-10-06 雪印乳業株式会社 乳由来カルシウム含有組成物及びその製造方法
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
US6139901A (en) * 1997-09-16 2000-10-31 New Zealand Milk Products (North Amerca) Inc. Membrane filtered milk proteins varying in composition and functional attributes
JP4592127B2 (ja) * 1999-03-30 2010-12-01 雪印乳業株式会社 骨吸収抑制剤
JP4701472B2 (ja) * 2000-04-21 2011-06-15 雪印乳業株式会社 乳カルシウム組成物の製造方法
JP2001346519A (ja) * 2000-06-09 2001-12-18 Snow Brand Milk Prod Co Ltd 乳塩基性シスタチン高含有画分及びその分解物の製造方法
AU784087B2 (en) * 2000-06-09 2006-02-02 Megmilk Snow Brand Co., Ltd. Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof
JP4647750B2 (ja) * 2000-06-20 2011-03-09 雪印乳業株式会社 乳塩基性シスタチン高含有画分及びその分解物の製造法
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
US20030026845A1 (en) * 2001-06-18 2003-02-06 Etzel Lisa R. Process for preparing protein isolate from milk, whey, colostrum, and the like
US20030118662A1 (en) * 2001-12-05 2003-06-26 Glanbia Foods, Inc. Therapeutic uses of milk mineral fortified food products
FR2841747B1 (fr) * 2002-07-02 2004-08-20 Cie Laitiere Europeenne Isolat de proteines de lait et procede pour sa preparation
JP2004115509A (ja) * 2002-09-05 2004-04-15 Snow Brand Milk Prod Co Ltd 破骨細胞分化抑制因子産生促進剤
KR100509177B1 (ko) * 2003-02-05 2005-08-22 롯데제과주식회사 골다공증 예방용 기능성 식품 조성물
JP4536341B2 (ja) * 2003-08-15 2010-09-01 雪印乳業株式会社 骨形成促進剤
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20050208638A1 (en) * 2004-03-22 2005-09-22 Chao Wu Process for preparing bioactive protein-enriched whey products
WO2006058083A2 (en) * 2004-11-24 2006-06-01 Cornell Research Foundation, Inc. Protein and calcium fortification system for clear and opaque beverages
WO2007062723A1 (en) * 2005-11-30 2007-06-07 Unilever N.V. Calcium fortified food product and additive
DE102006009799A1 (de) * 2006-03-01 2007-09-06 Henkel Kgaa Vorwiegend plättchenförmige schwer wasserlösliche Calciumsalze und/oder deren Kompositmaterialien, umfassend diese
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
WO2008028194A2 (en) * 2006-09-01 2008-03-06 Cornell Research Foundation, Inc. Calcium phosphate nanofibers
JP5657200B2 (ja) * 2008-09-05 2015-01-21 サントリー食品インターナショナル株式会社 乳清タンパク質の含有量が低減された乳組成物及び乳入り飲料
WO2011037957A2 (en) 2009-09-24 2011-03-31 U.S. Foods & Pharmaceuticals, Inc. Compositions and methods for bone repair, maintenance and regeneration

Also Published As

Publication number Publication date
EP2480099A2 (en) 2012-08-01
US20170027989A1 (en) 2017-02-02
WO2011038230A3 (en) 2011-08-11
WO2011037957A2 (en) 2011-03-31
US20110189337A1 (en) 2011-08-04
RU2012114489A (ru) 2013-10-27
EP2480099B1 (en) 2018-12-12
JP2013505950A (ja) 2013-02-21
AU2010298141A1 (en) 2012-04-19
WO2011038230A2 (en) 2011-03-31
WO2011037957A3 (en) 2012-02-23
US8557296B2 (en) 2013-10-15
RU2565020C2 (ru) 2015-10-10
CA2775276A1 (en) 2011-03-31
US20130029017A1 (en) 2013-01-31
NZ599184A (en) 2013-04-26
AU2010298141B2 (en) 2015-12-17
EP2480099A4 (en) 2015-05-27
US8518453B2 (en) 2013-08-27
US20140227409A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
Semler et al. First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI
Mahdy et al. Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences
CA2973883A1 (en) Methods of treating a subject with an alkaline phosphatase deficiency
de Villiers Bone health and osteoporosis in postmenopausal women
US20170027989A1 (en) Compositions and Methods for the Prevention and Treatment of Metabolic Diseases
Slivinska et al. Diagnostic informativeness of markers of bone-tissue metabolism and bone resorption in cows with osteodystrophy
Chinoy et al. Current status in therapeutic interventions of neonatal bone mineral metabolic disorders
Whyte et al. Rickets and osteomalacia
Whyte et al. Rickets and osteomalacia
Uçaktürk et al. Enzyme replacement therapy in hypophosphatasia
Prentice The effects of silicon on skeletal integrity in poultry
Barker et al. Diseases of the skeleton
O'Mara Hypophosphatemic Rickets: A Targeted Literature Review to Characterize the Multiple Causes of Phosphate Wasting Disorders and Identify Potential Disease Biomarkers
Bennett et al. Bone health and development
Liebross et al. Renal osteodystrophy
Yumol Determining If Lowering the Level of Dietary Calcium and Vitamin D in AIN-93G Diet Supports Normal Bone Development and Intestinal Integrity in Female CD-1 Mice
Behets et al. Gastrointestinal calcium absorption after ingestion of non calcium containing phosphate binders
Arundel et al. Evolution of the radiographic appearance of the metaphyses over the first year of life in type V osteogenesis imperfecta: clues to pathogenesis
Yacoub Assessment of Bone Minerals and Parathyroid Hormone Level in Postmenopausal Sudanese Women in Khartoum-State
Pritchard The Role Alterations in Dietary Calcium and Silicon Balance Play on Bone and Cartilage in Horses and Poultry
Schaafsma The influence of dietary calcium and phosphorus on bone metabolism
Colburn Metabolic Bone Disorders
Toure Effects of iodine and selenium depletion on growth and bone quality of rats
Huseman Skeletal Adaptation to Whole Body Vibration in Growing Pigs and Yearling Horses
SHARMA DIAGNOSTIC AND THERAPEUTIC STUDIES ON RICKETS IN DOGS

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150924

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251204

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260505

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260713